Bora Gurel

15PUBLICATIONS

222CO-AUTHORS

Predictive and prognostic markersTumour immunologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (15)

Sort by Publication Date:

|May 11, 2026

Immune Spatial Organization Predicts Distant Metastasis Risk in Aggressive Localized Prostate Cancer.

|Apr 27, 2026

Phase I trial of Ipatasertib plus Atezolizumab enhances PI3K/AKT pathway immune responses in solid tumors and refractory glioblastoma.

|Oct 08, 2025

Elucidating molecularly stratified single agent, and combination, therapeutic strategies targeting MCL1 for lethal prostate cancer.

Juan M Jiménez-Vacas, Daniel Westaby, Ines Figueiredo

|Jun 27, 2025

Defactinib with avutometinib in patients with solid tumors: the phase 1 FRAME trial.

Susana Banerjee, Matthew G Krebs, Alastair Greystoke

|May 28, 2025

BH3 mimetics targeting BCL-XL have efficacy in solid tumors with RB1 loss and replication stress.

Andreas Varkaris, Keshan Wang, Mannan Nouri

|Jan 09, 2025

NXP800 Activates the Unfolded Protein Response, Altering AR and E2F Function to Impact Castration-Resistant Prostate Cancer Growth.

Jonathan Welti, Denisa Bogdan, Ines Figueiredo

Pageof 3

Frequent Collaborators

13 joint publications

Johann S de Bono

Mateus Crespo

Jan Rekowski

Ruth Riisnaes

Ines Figueiredo

Suzanne Carreira

Ana Ferreira

Susana Miranda

Antje Neeb

Steven P Balk

Frequent Collaborators

13 joint publications

Johann S de Bono

7 joint publications

Mateus Crespo

6 joint publications

Jan Rekowski

6 joint publications

Ruth Riisnaes